Literature DB >> 4051833

Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine.

E Beghi, L T Kurland, D W Mulder, W C Wiederholt.   

Abstract

A study of the epidemiologic and clinical features of Guillain-Barré syndrome in the population of Olmsted County, Minnesota, over the 46-year period 1935 through 1980 was conducted through the centralized diagnostic index maintained at Mayo Clinic, Rochester, Minn. A total of 48 cases were identified, giving an age- and sex-adjusted incidence of 1.8 per 100,000 person-years. The rate increased over time from 1.2 in the interval 1935 through 1956 to 2.4 in the interval 1970 through 1980. Males were affected more than females (age-adjusted rates of 2.3 and 1.2, respectively). The rate increased with age from 0.8 in those under 18 years old to 3.2 for those 60 years and older. Antecedent infectious diseases were reported in 65% of the cases. Implications with regard to the incidence of Guillain-Barré syndrome associated with the A/New Jersey/76 (swine flu) vaccine are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051833     DOI: 10.1001/archneur.1985.04060100035016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  Lesson of the week: A painful hip as a presentation of Guillain-Barré syndrome in children.

Authors:  T Tang; C Noble-Jamieson
Journal:  BMJ       Date:  2001-01-20

Review 2.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

3.  The Guillain-Barrè syndrome (GBS). Implementation of a register of the disease on a nationwide basis. Italian GBS Study Group.

Authors:  E Beghi; G Bogliun
Journal:  Ital J Neurol Sci       Date:  1996-10

4.  Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  Guillain-Barré syndrome and serum activities of gamma-glutamyltransferase and glutamic-pyruvic transaminase.

Authors:  J Kornhuber; A W Kornhuber; C H Kaiserauer; W E Wanner
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

Review 6.  Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis.

Authors:  James J Sejvar; Andrew L Baughman; Matthew Wise; Oliver W Morgan
Journal:  Neuroepidemiology       Date:  2011-03-21       Impact factor: 3.282

7.  Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.

Authors:  G X Jiang; Q Cheng; H Link; J de Pedro-Cuesta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

8.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

9.  Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.

Authors:  H J Bernsen; A M Van Loon; R F Poels; W I Verhagen; C W Frenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

10.  Miller Fisher syndrome.

Authors:  Suresh Kumar Gupta; Kunal Kishor Jha; Mhd Diaa Chalati; Losan Tareq Alashi
Journal:  BMJ Case Rep       Date:  2016-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.